Multidisciplinary consensus: A practical guide for the integration of abiraterone into clinical practice
![Cancers | Free Full-Text | The Prostate Cancer Therapy Enzalutamide Compared with Abiraterone Acetate/Prednisone Impacts Motivation for Exploration, Spatial Learning and Alters Dopaminergic Transmission in Aged Castrated Mice Cancers | Free Full-Text | The Prostate Cancer Therapy Enzalutamide Compared with Abiraterone Acetate/Prednisone Impacts Motivation for Exploration, Spatial Learning and Alters Dopaminergic Transmission in Aged Castrated Mice](https://www.mdpi.com/cancers/cancers-13-03518/article_deploy/html/images/cancers-13-03518-g001.png)
Cancers | Free Full-Text | The Prostate Cancer Therapy Enzalutamide Compared with Abiraterone Acetate/Prednisone Impacts Motivation for Exploration, Spatial Learning and Alters Dopaminergic Transmission in Aged Castrated Mice
![Enzalutamide versus abiraterone as a first-line endocrine therapy for castration-resistant prostate cancer (ENABLE study for PCa): a study protocol for a multicenter randomized phase III trial | BMC Cancer | Full Text Enzalutamide versus abiraterone as a first-line endocrine therapy for castration-resistant prostate cancer (ENABLE study for PCa): a study protocol for a multicenter randomized phase III trial | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-017-3661-2/MediaObjects/12885_2017_3661_Fig1_HTML.gif)
Enzalutamide versus abiraterone as a first-line endocrine therapy for castration-resistant prostate cancer (ENABLE study for PCa): a study protocol for a multicenter randomized phase III trial | BMC Cancer | Full Text
![2011 Prostate Cancer Highlights, Prostate Cancer Research Program, Congressionally Directed Medical Research Programs 2011 Prostate Cancer Highlights, Prostate Cancer Research Program, Congressionally Directed Medical Research Programs](https://cdmrp.health.mil/images/misc/wilding_figure.jpg)
2011 Prostate Cancer Highlights, Prostate Cancer Research Program, Congressionally Directed Medical Research Programs
![TSPYL Family Regulates CYP17A1 and CYP3A4 Expression: Potential Mechanism Contributing to Abiraterone Response in Metastatic Castration‐Resistant Prostate Cancer - Qin - 2018 - Clinical Pharmacology & Therapeutics - Wiley Online Library TSPYL Family Regulates CYP17A1 and CYP3A4 Expression: Potential Mechanism Contributing to Abiraterone Response in Metastatic Castration‐Resistant Prostate Cancer - Qin - 2018 - Clinical Pharmacology & Therapeutics - Wiley Online Library](https://ascpt.onlinelibrary.wiley.com/cms/asset/8d2e3ea1-7721-4d85-a4c4-0be5962949ac/cpt907-fig-0006-m.jpg)
TSPYL Family Regulates CYP17A1 and CYP3A4 Expression: Potential Mechanism Contributing to Abiraterone Response in Metastatic Castration‐Resistant Prostate Cancer - Qin - 2018 - Clinical Pharmacology & Therapeutics - Wiley Online Library
![Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is born - Michael T. Schweizer, Emmanuel S. Antonarakis, 2012 Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is born - Michael T. Schweizer, Emmanuel S. Antonarakis, 2012](https://journals.sagepub.com/cms/10.1177/1756287212452196/asset/images/large/10.1177_1756287212452196-fig2.jpeg)
Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is born - Michael T. Schweizer, Emmanuel S. Antonarakis, 2012
![Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302) final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 ... Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302) final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 ...](http://www.oncoprescribe.com/app/uploads/_1423058163.jpg)
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302) final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 ...
![Zytiga (Abiraterone J&J) for Treatment of Prostate Cancer (mCRPC) - Prostate Cancer Specialists in NYC Zytiga (Abiraterone J&J) for Treatment of Prostate Cancer (mCRPC) - Prostate Cancer Specialists in NYC](https://www.newyorkurologyspecialists.com/prostate-cancer/wp-content/uploads/sites/4/2014/04/testosterone_shutterstock_121159390.jpg)
Zytiga (Abiraterone J&J) for Treatment of Prostate Cancer (mCRPC) - Prostate Cancer Specialists in NYC
![AUA 2012 - mCRPC in focus: Androgen biosynthesis inhibition and metastatic castration-resistant prostate cancer, clinical insights from the Clinical Industry Theater presentation by Judd Moul, MD AUA 2012 - mCRPC in focus: Androgen biosynthesis inhibition and metastatic castration-resistant prostate cancer, clinical insights from the Clinical Industry Theater presentation by Judd Moul, MD](https://www.urotoday.com/images/stories/conferences/aua_2012/moul_slide2.jpg)
AUA 2012 - mCRPC in focus: Androgen biosynthesis inhibition and metastatic castration-resistant prostate cancer, clinical insights from the Clinical Industry Theater presentation by Judd Moul, MD
![Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is born - Michael T. Schweizer, Emmanuel S. Antonarakis, 2012 Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is born - Michael T. Schweizer, Emmanuel S. Antonarakis, 2012](https://journals.sagepub.com/cms/10.1177/1756287212452196/asset/images/large/10.1177_1756287212452196-fig1.jpeg)
Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is born - Michael T. Schweizer, Emmanuel S. Antonarakis, 2012
![Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses | Arteriosclerosis, Thrombosis, and Vascular Biology Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/b9d8ad9b-b30c-4a46-917f-ca4480c8c3c2/atvbaha.119.313046ga1.jpg)